Myelodysplastic syndromes (MDS)
Myelodysplastic syndromes (MDS) are a group of blood disorders where a person’s bone marrow does not produce the correct amount and quality of blood cells. It is often considered a premalignant stage meaning that MDS can progress into leukaemia. Red cells, white cells and platelets can be affected in MDS. These problems make people with MDS feeling very tired, weak and bleeding or bruising more easily. There are different levels of severity of MDS, and monitoring of MDS is important to predict the risk of progression to leukaemia.